Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2015 | R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability | Chen H.-Y.; Yu S.-L.; Ho B.-C.; Su K.-Y.; Hsu Y.-C.; Chang C.-S.; Li Y.-C.; Yang S.-Y.; Hsu P.-Y.; Ho H.; Chang Y.-H.; Chen C.-Y.; Yang H.-I.; Hsu C.-P.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Hsia J.-Y.; Chuang C.-Y.; Yuan S.; Lee M.-H.; Liu C.-H.; Wu G.-I.; Hsiung C.A.; Chen Y.-M.; Wang C.-L.; Huang M.-S.; CHONG-JEN YU ; Chen K.-Y.; Tsai Y.-H.; Su W.-C.; Chen H.-W.; Chen J.J.W.; Chen C.-J.; Chang G.-C.; Yang P.-C.; Li K.-C. | Journal of Clinical Oncology | | | |
2019 | Radial endobronchial ultrasound-guided transbronchial biopsy for peripheral pulmonary malignancy: Biopsy- or brushing-first? | Huang C.-T.; Tsai Y.-J.; Ho C.-C.; CHONG-JEN YU | BMC Pulmonary Medicine | | | |
2008 | Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response | Gow C.-H.; Chien C.-R.; Chang Y.-L.; Chiu Y.-H.; Kuo S.-H.; Shih J.-Y.; Chang Y.-C.; CHONG-JEN YU ; Yang C.-H.; Yang P.-C. | Clinical Cancer Research | | | |
2009 | Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer | Mok T.S.K.; Wu Y.-L.; CHONG-JEN YU ; Zhou C.; Chen Y.-M.; Zhang L.; Ignacio J.; Liao M.; Srimuninnimit V.; Boyer M.J.; Chua-Tan M.; Sriuranpong V.; Sudoyo A.W.; Jin K.; Johnston M.; Chui W.; Lee J.-S. | Journal of Clinical Oncology | | | |
2017 | Rapid Sputum Multiplex Detection of the M. tuberculosis Complex (MTBC) and Resistance Mutations for Eight Antibiotics by Nucleotide MALDI-TOF MS | Su K.-Y.; Yan B.-S.; Chiu H.-C.; CHONG-JEN YU ; Chang S.-Y.; Jou R.; Liu J.-L.; Hsueh P.-R.; Yu S.-L. | Scientific Reports | | | |
2011 | A rare constellation of empyema, lung abscess, and mediastinal abscess as a complication of endobronchial ultrasound-guided transbronchial needle aspiration | Huang C.-T.; Chen C.-Y.; Ho C.-C.; CHONG-JEN YU | European Journal of Cardio-thoracic Surgery | | | |
2019 | A rare epidermal growth factor receptor H773L/V774M compound mutation in advanced non-small-cell lung cancer with poor response to epidermal growth factor receptor tyrosine kinase inhibitor | Chen L.-C.; Shih J.-Y.; CHONG-JEN YU ; Yang C.-Y. | Respirology Case Reports | | | |
2017 | Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib | Yao Z.-H.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.H.; CHONG-JEN YU | Oncologist | | | |
2019 | Recommendations and guidelines for the treatment of pneumonia in Taiwan | Chou C.-C.; Shen C.-F.; Chen S.-J.; Chen H.-M.; Wang Y.-C.; Chang W.-S.; Chang Y.-T.; Chen W.-Y.; Huang C.-Y.; Kuo C.-C.; Li M.-C.; Lin J.-F.; Lin S.-P.; Ting S.-W.; Weng T.-C.; Wu P.-S.; Wu U.-I.; Lin P.-C.; Lee S.S.-J.; Chen Y.-S.; Liu Y.-C.; Chuang Y.-C.; CHONG-JEN YU ; Huang L.-M.; Lin M.-C.; Infectious Diseases Society of Taiwan; , Taiwan Society of Pulmonary; Critical Care Medicine,, Medical Foundation in Memory of Dr. Deh-Lin Cheng; , Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research; Education; , CY Lee's Research Foundation for Pediatric Infectious Diseases; Vaccines,, The 4th Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group | Journal of Microbiology, Immunology and Infection | | | |
2004 | Relapse of SARS upon tapering corticosteroid | Chien J.-Y.; Hsueh P.-R.; Chang S.-C.; Hwang J.-J.; CHONG-JEN YU ; Yang P.-C. | Intensive Care Medicine | | | |
2015 | Response to: "Antimicrobial drug-resistant microbes have a higher risk of health care-associated pneumonia in eastern Taiwan" | Wu C.-L.; CHONG-JEN YU | Journal of the Formosan Medical Association | | | |
2007 | Revisit of 1997 TNM staging system - Survival analysis of 1112 lung cancer patients in Taiwan | Perng R.-P.; Chen C.-Y.; Chang G.-C.; Hsia T.-C.; Hsu N.-Y.; Tsai Y.-H.; Tsai C.-M.; Yang C.-H.; Chen Y.-M.; CHONG-JEN YU ; Lee J.-J.; Hsu H.-S.; Yu C.-T.; Kao E.-L.; Chiu C.-H. | Japanese Journal of Clinical Oncology | | | |
2012 | Revisiting tuberculous pleurisy: Pleural fluid characteristics and diagnostic yield of mycobacterial culture in an endemic area | Ruan S.-Y.; Chuang Y.-C.; Wang J.-Y.; Lin J.-W.; Chien J.-Y.; Huang C.-T.; Kuo Y.-W.; Lee L.-N.; CHONG-JEN YU | Thorax | | | |
2003 | Rhabdomyolysis associated with probable SARS [8] | Wang J.-L.; Wang J.-T.; CHONG-JEN YU ; Chen Y.-C.; Hsueh P.-R.; Hsiao C.-H.; Kao C.-L.; Chang S.-C.; Yang P.-C. | American Journal of Medicine | | | |
2012 | Risk factors for Mycobacterium chelonae-abscessus pulmonary disease persistence and deterioration | Lee M.-R.; Keng L.-T.; Shu C.-C.; Lee S.-W.; Lee C.-H.; Wang J.-Y.; Lee L.-N.; CHONG-JEN YU ; Yang P.-C. | Journal of Infection | | | |
2011 | Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load | Wang J.-Y.; Liu C.-H.; Hu F.-C.; Chang H.-C.; Liu J.-L.; Chen J.-M.; CHONG-JEN YU ; Lee L.-N.; Kao J.-H.; Yang P.-C. | Journal of Infection | | | |
2012 | Risk Factors of Pneumothorax after Endobronchial Ultrasound-Guided Transbronchial Biopsy for Peripheral Lung Lesions | Huang C.-T.; Ruan S.-Y.; Liao W.-Y.; Kuo Y.-W.; Lin C.-Y.; Tsai Y.-J.; Ho C.-C.; CHONG-JEN YU | PLoS ONE | | | |
2019 | Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists | Wang C.-Y.; Lin Y.S.; Wang Y.-H.; Lai C.-C.; Wang H.-C.; Chen L.; CHONG-JEN YU ; CHONG-JEN YU ; Wang H.-C.; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Tsai Y.-H.; Hsiue T.-R.; Lin M.-C.; Lin H.-I.; Wang C.-Y.; Chang Y.-C.; Yang U.-C.; Chen C.-M.; Lin C.-S.; Chen L.; Wei Y.-F.; Chong I.-W.; Chen C.-Y.; On the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) | Aging | | | |
2019 | Risk of Sepsis and Mortality Among Patients With Chronic Obstructive Pulmonary Disease Treated With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers | Lai C.-C.; Wang Y.-H.; Wang C.-Y.; Wang H.-C.; CHONG-JEN YU ; Chen L.; Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) | Critical Care Medicine | | | |
2016 | Risk of tuberculosis among patients on dialysis | Shu C.-C.; Hsu C.-L.; Wei Y.-F.; Lee C.-Y.; Liou H.-H.; Wu V.-C.; Yang F.-J.; Lin H.-H.; Wang J.-Y.; Chen J.-S.; CHONG-JEN YU ; Lee L.-N. | Medicine (United States) | | | |